Crossmark

Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing

Crossref DOI link: https://doi.org/10.1186/s12943-018-0875-0

Published Online: 2018-08-28

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, Qiaomei

Wang, Junlei https://orcid.org/0000-0001-8104-5558
Xiao, Jianfeng

Wang, Lin

Hu, Xiaomeng

Yu, Wenjun

Song, Gang

Lou, Jiatao

Chen, JianFeng https://orcid.org/0000-0002-2892-1691
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (31525016, 81672833)

Ministry of science and technology of china (2014DFA33010)

Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12010101)

CAS/SAFEA International Partnership Program for Creative Research Teams and Shanghai Hospital Development Center (SHDC22014011)
License Information

Text and Data Mining valid from 2018-08-28
More Information

Article History

Received: 20 April 2018

Accepted: 9 August 2018

First Online: 28 August 2018

Ethics approval and consent to participate

: All human samples are collected under an Institutional Review Board approved protocol (No.KS (P)1801).

: Written informed consent was obtained from the patients for publication of this letter.

: The authors declare no competing financial interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.